Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -177.97% | -121.55% | 176.31% | 18.10% | -48.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -177.97% | -121.55% | 176.31% | 18.10% | -48.71% |
| Cost of Revenue | -184.77% | -128.73% | 7.09% | -19.99% | -61.76% |
| Gross Profit | -176.52% | -119.68% | 273.57% | 29.25% | -44.67% |
| SG&A Expenses | -151.96% | -107.94% | 112.64% | 23.09% | -36.50% |
| Depreciation & Amortization | -259.31% | -211.78% | 212.77% | -13.80% | -65.54% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -159.31% | -113.47% | 92.28% | 14.46% | -42.10% |
| Operating Income | 116.48% | 93.78% | 17.19% | -2.92% | 17.79% |
| Income Before Tax | 115.57% | 80.25% | -2.63% | -9.87% | 52.18% |
| Income Tax Expenses | -185.25% | -185.25% | -- | -- | 251.08% |
| Earnings from Continuing Operations | 122.01% | 78.74% | -69.04% | -75.96% | 60.75% |
| Earnings from Discontinued Operations | -132,033.33% | -132,033.33% | -1,727.03% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 221.53% | 201.76% | 203.77% | 206.49% | -7.11% |
| EBIT | 116.48% | 93.78% | 17.19% | -2.92% | 17.79% |
| EBITDA | 125.95% | 104.77% | 3.61% | -11.65% | 24.83% |
| EPS Basic | 222.18% | 201.77% | 203.00% | 205.36% | -4.12% |
| Normalized Basic EPS | 112.20% | 82.20% | 4.42% | -4.24% | 15.89% |
| EPS Diluted | 213.87% | 194.11% | 194.44% | 198.16% | -3.15% |
| Normalized Diluted EPS | 113.39% | 86.25% | 13.91% | 5.00% | 14.19% |
| Average Basic Shares Outstanding | 0.45% | 0.92% | 3.02% | 2.45% | 2.05% |
| Average Diluted Shares Outstanding | 0.53% | 2.44% | 3.53% | 2.98% | 2.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |